Home » Topics » BioWorld Science

BioWorld Science
RSS

SERPINA1 is associated with poor prognosis and liver metastasis in gastric cancer

July 5, 2022

Knockout models may reveal role of CRIPTO in castration-resistant prostate cancer

July 5, 2022

ACT-02 improves neurodegeneration in mouse model of PD

July 5, 2022

New Gly12Cys mutant GTPase KRAS inhibitors patented by Abbisko Therapeutics

July 5, 2022

Jiangsu Zhengda Qingjiang Pharmaceutical presents SLC22A12 inhibitors

July 5, 2022

New protein kinase B inhibitors identified at Nanjing Zhengda Tianqing Pharmaceutical

July 5, 2022

University of Queensland, James Cook University describe new therapeutic peptides

July 5, 2022

Mindset Pharma discovers 5-HT2A receptor agonists

July 5, 2022

PTPRK predicts poor prognosis in patients with pancreatic cancer

July 5, 2022

Targeting RNF41 promotes liver regeneration in mice

July 5, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...